Drug lookup
Drug reference

Acebutolol

Beta Blocker · Antihypertensive, Antiarrhythmic, Antianginal

Also known as Acebutolol hydrochloride

Beta BlockerAntihypertensive, Antiarrhythmic, AntianginalATC C07AB04
CDSCO approvedATC C07AB04
EXCRETION
not curated
INTERACTIONS
12 major
SEVERE in our sources
PREGNANCY
not curated
Top interactionssee all 12
  • AdrenalineSevereTextbookKDT 7e · p133
  • AmilorideSevereTextbookKDT 7e
  • SofosbuvirSevereTextbookHarrison 22e · unknown
  • AminophyllineSevereDatabaseDDInter

Mechanism

Acebutolol is a beta-adrenoceptor blocking drug that blocks beta-adrenoceptors in the heart, peripheral vasculature, bronchi, pancreas, and liver. It slows the heart and can depress the myocardium. Due to its intrinsic sympathomimetic activity, it tends to cause less bradycardia. In hypertension, it reduces cardiac output, alters baroreceptor reflex sensitivity, blocks peripheral adrenoceptors, and may depress plasma renin secretion.

Indications

HypertensionArrhythmiasSevere anginaventricular and atrial cardiac arrhythmiasacute myocardial infarction (in high-risk patients)Smith-Magenis syndrome

Dosing

Adult
Hypertension: Initially 400 mg daily, alternatively initially 200 mg twice daily; maximum 1.2 g per day by mouth. Arrhythmias: 0.4–1.2 g daily in 2–3 divided doses by mouth. Severe angina: Initially 300 mg 3 times a day; maximum 1.2 g per day by mouth.
Renal adjustment
Halve dose if eGFR 25–50 mL/minute/1.73 m2; use quarter dose if eGFR less than 25 mL/minute/1.73 m2; do not administer more than once daily.
Max dose
1.2 g per day

Pharmacokinetics

Half-life
about 3 h (acebutolol); 8 to 12 h (diacetolol, active metabolite)
Bioavailability
35% to 50% (oral)
Protein binding
lipophilic, crosses blood-brain barrier
Metabolism
undergoes significant first-pass metabolism to active metabolite diacetolol
Excretion
By the kidneys (as a water-soluble beta-blocker)

Contraindications

  • Second- or third-degree heart block
  • Worsening unstable heart failure
  • History of asthma
  • Frequent episodes of hypoglycaemia
  • abrupt discontinuation (withdrawal syndrome)

Side effects

Common
Gastrointestinal disorderFatigueColdness of the extremitiesSleep disturbances with nightmares
Serious
  • Cyanosis
  • Hepatic disorders
  • Lupus-like syndrome
  • Nervous system disorder
  • Psychosis
  • Respiratory disorders (e.g., bronchospasm)
  • Sexual dysfunction
  • Hypoglycaemia
  • Hyperglycaemia
  • Masking of hypoglycaemia symptoms
  • life-threatening bradyarrhythmias (with AV conduction defects or other drugs)
  • exacerbation of angina (abrupt discontinuation)
  • increased risk of sudden death (abrupt discontinuation)
  • blunted recognition/delayed recovery from hypoglycemia

Pregnancy & lactation

Lactation

Present in breast milk in greater amounts than other beta-blockers.

Drug interactions

Adrenaline
Severe
Textbook

Marked rise in BP.

Adrenaline should not be given to patients receiving β blockers.

Source: KDT 7e · p133

Amiloride
Severe
Textbook

Hyperkalaemia more likely.

Source: KDT 7e

Sofosbuvir
Severe
Textbook

Severe bradycardia.

Extreme caution advised if amiodarone is co-administered with sofosbuvir and a beta blocker.

Source: Harrison 22e · unknown

Aminophylline
Severe
Database

Drug interaction classified as: antagonism

Source: DDInter

Arbutamine
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Atazanavir
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Ceritinib
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Clonidine
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Diltiazem
Severe
Database

Increased propensity for AV block, severe bradycardia, and decreased left ventricular function.

Avoid concurrent administration. The concurrent administration of diltiazem with a beta blocker is contraindicated.

Source: DDInter

Disopyramide
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Dolasetron
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Dyphylline
Severe
Database

Drug interaction classified as: antagonism

Source: DDInter

Related guidelines

Other Beta Blocker drugs

Ask House about Acebutolol

Continue into a citation-backed clinical answer with the drug context already attached.

Sources: KD Tripathi 7e, Goodman & Gilman 14e, Katzung, BNF·Verified: 2026-05-10 · House clinical team